NEW YORK (Thomson Financial) - Dow component Pfizer Inc. Tuesday said that
its Explorer Acquisition Corp. unit extended the offering period for a tender
offer of Encysive Pharmaceuticals shares to April 14.
The offering had previously been set to expire on April 7. As of that date,
83.3% of the outstanding shares had been tendered.
Explorer Acquisition is offering to buy Encysive shares for $2.35 a share in
cash.
Shares of Pfizer, a pharmaceutical company, closed Monday at $21.48.
Encysive shares closed at $2.35.
Ryan Vlastelica
rv/tk1
COPYRIGHT
Copyright Thomson Financial News Limited 2007. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|